Inhibiting or removing USP7 disrupts homologous recombination repair (HRR), causing a significant buildup of DNA damage and leading to CLL cell apoptosis, even in cases where ATM and p53 are dysfunctional. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.